Quote:
Originally Posted by Birgitta-A
Hi All,
As MDS Beacon reported there is a study at ASH showing positive results for treatment with so called SSRI drugs for depression in MDS patients. SSRI treatment promotes normalization of deranged proinflammatory cytokines in patients diagnosed with depression such as TNF α and IL12. https://ash.confex.com/ash/2012/webp...aper54539.html
Kind regards
Birgitta-A |
Do you know of any studies for low-intermediate risk and SSRI? This one suggests it works for low-risk. Thank you 
__________________
DX MDS RA Low Risk August 2012. DX Changed to MDS RAEB1. Progressed to AML July 2013. Participated in clinical chemo trial CPX351 and relapsed four months later in March 2014. Maintenance chemo -VIDAZA (AZA) stopped after 4 rounds. Awaiting full report from BMB.
|